Table 2.
Cancer incidence and frequency
| Incidence | Frequency (%) | |
|---|---|---|
| P53−/− (n=52) | ||
| Lymphoma | 15 | 29 |
| Hemangiosarcoma | 14 | 27 |
| Myeloid leukemia | 11 | 21 |
| Anaplastic sarcoma | 9 | 17 |
| Myeloid proliferation | 5 | 10 |
| Adrenocortical carcinoma | 4 | 8 |
| Osteosarcoma | 3 | 6 |
| Pancreatic adenocarcinoma | 2 | 4 |
| Plasma cell tumor | 1 | 2 |
| Squamous cell carcinoma | 1 | 2 |
| Renal adenocarcinoma | 0 | 0 |
| P53+/− (n=30) | ||
| Lymphoma | 20 | 67 |
| Hemangiosarcoma | 5 | 17 |
| Myeloid leukemia | 2 | 6 |
| Anaplastic sarcoma | 0 | 0 |
| Myeloid proliferation | 1 | 3 |
| Adrenocortical carcinoma | 1 | 3 |
| Osteosarcoma | 1 | 3 |
| Pancreatic adenocarcinoma | 0 | 0 |
| Plasma cell tumor | 0 | 0 |
| Squamous cell carcinoma | 0 | 0 |
| Renal adenocarcinoma | 1 | 3 |